92 filings
Page 2 of 5
8-K
m6em holp7fxfgf6e4o2
27 Dec 22
Entry into a Material Definitive Agreement
7:02am
8-K
tbh0cqsk
22 Dec 22
Entry into a Material Definitive Agreement
12:00am
8-K
7ehesdx78xy4pfhh
7 Nov 22
Entry into a Material Definitive Agreement
4:05pm
8-K
l6ab64sm gr5x5b
7 Nov 22
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results
7:10am
8-K
depm rcpu
6 Oct 22
Mersana Therapeutics Announces Completion of Enrollment in UPLIFT, a
4:21pm
8-K
j5k c1mxr
16 Aug 22
Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-1660 in Breast, Endometrial and Ovarian Cancers
8:18am
8-K
09uy9
8 Aug 22
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2022 Financial Results
4:11pm
8-K
ujo3ihjdydfx g6j
8 Aug 22
Entry into a Material Definitive Agreement
4:06pm
8-K
u66 irma94n9d
10 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
h9elkcnk
9 May 22
Mersana Therapeutics Provides Business Update and Announces First Quarter 2022 Financial Results
7:08am
8-K
sq5y1ecx pd
28 Feb 22
Entry into a Material Definitive Agreement
5:14pm
8-K
b3boxrcejp93 2l
28 Feb 22
Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
6:16am
8-K
jv9kue2m
3 Feb 22
Entry into a Material Definitive Agreement
7:15am
8-K
jc7xodln7rc8wg
23 Nov 21
Entry into a Material Definitive Agreement
7:16am
8-K
0qs51morusme kqsv3m3
9 Nov 21
Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
6:15am
8-K
nks ioq5ssip
29 Oct 21
Entry into a Material Definitive Agreement
5:25pm
8-K
ei671slv
10 Sep 21
Other Events
7:50am
8-K
ww3dkob jjemi59dvwv
16 Aug 21
Mersana Therapeutics Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturing Officer
8:16am
8-K
h0zdfoew g66l
6 Aug 21
Mersana Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
6:30am
8-K
1czlfr rv4
17 Jun 21
Submission of Matters to a Vote of Security Holders
6:30am